Metabolic Risk Susceptibility in Men Is Partially Related to Adiponectin/Leptin Ratio

Table 1

Subject demography and baseline characteristics.

	Nonobese	Overweight	Obese
Waist girth category	<90 cm	90–101 cm	≥102 cm
Number of men (% of total)	55 (13)	147 (34)	226 (53)
Age (±SD) (years)	53.0 (8.9)	54.1 (10.2)	55.4 (9.6)
Body mass index (kg/m^2)	24.1 (2.3)	27.9 (2.5)^b	33.6 (4.1)^a
Waist girth (cm)	85.3 (3.6)	95.9 (2.9)^b	112.8 (9.3)^a
Systolic blood pressure (Hg mm)	132.1 (17.9)^c	138.3 (16.7)	142.5 (16.7)
Diastolic blood pressure (Hg mm)	79.1 (12.9)^c	82.3 (9.7)	83.0 (8.9)
Hemoglobin A1c (%), Median (IQ)*	5.4 (.4)	5.4 (.5)	5.5 (.6)
Glucose (mg/dL)	93.3 (9.3)^d	94.9 (10.0)	97.0 (11.3)
HOMA2-IR median (IQ)	1.16 (.98)	1.57 (.77)	2.13 (1.53)^a
HOMA2%𝛽, median (IQ)	97.5 (51.9)	119.8 (47.4)	139.9 (70.6)
HOMA2%S, median (IQ)	86.5 (101.7)	63.7 (33.3)^b	46.9 (36.4)^a
Adiponectin μg/mL, median (IQ)	8.9 (87.6)^c	7.7 (4.8)	7.5 (4.7)
Leptin ng/mL, median (IQ)	2.3 (2.2)	5.2 (3.9)^b	10.4 (7.5)^a
Triglyceride, median (IQ)	110 (68)	153 (104)^b	186 (92)^a
HDL cholesterol mg/dL	47 (15)	39 (15)^b	37 (9)^a
Non-HDL cholesterol mg/dL	147 (44)	166 (43)	165 (47)
Total Apo B mg/dL	116 (29)	126 (28)^b	129 (26)^a
Hypertension (%)	52.6	75.5	88.8
Smokers (%)	.0	3.7	1.5

aSignificantly different from non-obese and overweight (𝑃<.02); ^bsignificantly different from non-obese (𝑃<.02); ^csignificantly different from overweight and from obese (𝑃<.02); ^dsignificantly different from obese (𝑃<.02); *IQ: interquartile.